An internal 2005 U.S. Army study reported that improper use of antibiotics and unsanitary conditions at military hospitals contributed to a deadly outbreak of Acinetobacter infections — not Iraqi dirt in soldiers’ blast wounds, as officials publicly claimed until 2007.
Scant market incentives have left the pharmaceutical industry slow to tackle urgently-needed development of new antibacterial drugs, according to a new report from the World Health Organization.
Urgent call for research to optimize dosage guidelines as scattered case studies suggest emergence of bacterial resistance to Colistin, a last-line treatment for many.
Scientists at SRI International failed to identify any non-antibiotic drugs among 1,040 FDA-approved medications that could be ‘repurposed’ as weapons against Acinetobacter.
More evidence multidrug-resistant Acinetobacter — and inappropriate antibiotic prescribing by doctors — kills patients.
The Acinetobacter Threat: Australian researchers are calling for a major new effort to develop entirely new antibiotics to counter the growing threat posed by Acinetobacter bacterial infections.
The Acinetobacter Threat: a new meta-analysis of mortality risk factors in adult ventilator pneumonia suggests Acinetobacter infections, hospital policies and practices all play major roles in whether or not a patient survives.
The Acinetobacter Threat: Multidrug-resistant (MDR) Acinetobacter appears to be more easily transmitted than other hospital infections. The gloves, gowns and unwashed hands of health care workers are frequently contaminated with Acinetobacter, a new study reports.